MYMing Yuan

Ming Yuan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ming Yuan has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Chi Zhang

    Department of General Surgery (Colorectal Surgery) The Sixth Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong 510655 China

    2 shared publications
  • Haoxian Ke

    Department of Gastrointestinal Surgery Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou Guangdong 510288 China

    2 shared publications
  • Junfeng Huang

    Department of Gastrointestinal Surgery Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou Guangdong 510288 China

    2 shared publications
  • Ping Lan

    Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

    2 shared publications
  • Shubiao Ye

    Department of General Surgery (Colorectal Surgery) The Sixth Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong 510655 China

    2 shared publications
  • Xianrui Wu

    Department of Gastrointestinal Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China

    2 shared publications

Latest Publications

  • Open Access

    ACSS2‐Mediated Histone H4 Lysine 12 Crotonylation (H4K12cr) Alleviates Colitis via Enhancing Transcription of CLDN7

    by Ming Yuan, Shaopeng Chen, Zhensen Lin, Runfeng Yu, Kang Chao, Shubiao Ye, Qing Li, Haoxian Ke, Chi Zhang, Junfeng Huang, et al.

    Histone lysine crotonylation (Kcr), a highly conserved posttranslational modification, plays critical roles in various biological processes. Nevertheless, the dynamic alterations and functions of histone Kcr in inflammatory bowel disease (IBD) remain poorly explored. Herein, a notable decrease of both Pan‐Kcr and ACSS2 (acyl‐CoA synthetase short‐chain family member 2), the key enzyme for crotonyl‐CoA generation, is revealed in inflamed intestinal epithelial cells. Genetic or pharmacological inhibition of ACSS2 dramatically impairs mouse intestinal barrier integrity and exacerbates colitis. Mechanistically, ACSS2‐mediated histone H4 lysine 12 crotonylation (H4K12cr) upregulates CLDN7 expression to fortify intestinal epithelial barrier, which can be augmented by crotonate supplementation. Furthermore, tumor necrosis factor‐α (TNF‐α) is revealed to enhance the m6A modification of ACSS2 mRNA, consequently destabilizing and downregulating ACSS2 . Combinational therapy involving anti‐TNF‐α and crotonate can significantly ameliorate colitis. Overall, ACSS2‐mediated H4K12cr emerges as a pivotal modulator governing intestinal barrier function during IBD progression.


  • Open Access

    MTHFD1 Regulates Autophagy to Promote Growth and Metastasis in Colorectal Cancer via the PI3K‐AKT–mTOR Signaling Pathway

    by Zhihao Li, Haoxian Ke, Jiawei Cai, Shubiao Ye, Junfeng Huang, Chi Zhang, Ming Yuan, Ping Lan, Xianrui Wu

    Objectives: Methylenetetrahydrofolate dehydrogenase 1 (MTHFD1) is the enzyme with the activities of methylenetetrahydrofolate dehydrogenase, methylenetetrahydrofolate cyclohydrolase, and formyltetrahydrofolate synthetase. Our aim was to elucidate the function of MTHFD1 in colorectal cancer (CRC).Methods: In vitro assessments of the proliferation, invasion, and migration abilities of CRC cells were conducted using Immunohistochemistry, Transwell invasion assays, Western blot (WB), and Cell counting Kit‐8 assays. WB was also utilized to measure autophagy protein levels and PI3K‐AKT‐mTOR signaling pathway expression. Furthermore, the role of MTHFD1 was evaluated in vivo by using subcutaneous xenograft tumor models and lateral tail vein metastasis models of human CRC in nude mice.Results: Overexpression of MTHFD1 promoted the abilities of tumorigenesis and metastasis in CRC in vitro and in vivo and reduced autophagy, attributing to the PI3K‐AKT‐mTOR signaling pathway in CRC cells. In contrast, the down‐regulation of MTHFD1 increased autophagy and suppressed their proliferation, migration, and invasion.Conclusions: MTHFD1 can modulate the PI3K‐AKT‐mTOR signaling pathway to suppress autophagy and stimulate tumorigenesis and metastasis.